CPT code 28045 denotes surgical excision of an abnormal soft-tissue mass from within the muscles of the foot or toe, with specimen submission under 1.5 cm for laboratory analysis. The code is relevant nationally for foot and ankle surgeons, podiatrists, and health systems managing benign and malignant soft-tissue lesions of the distal lower extremity. Accurate coding affects clinical documentation, pathology processing, and claims adjudication across commercial and public payers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on clinical indications and typical sites of service for the procedure, common billing considerations, and comparative coverage patterns among major payers. The publication summarizes national benchmarks where available, highlights areas where policy language commonly affects payment and documentation, and outlines the clinical workflow tied to specimen submission for pathology.

The content is intended for coding professionals, billing managers, clinical leaders, and policy analysts seeking a concise reference on CPT code 28045, its clinical scope, and implications for reimbursement and documentation. Data not available in the input is noted where applicable.